Insider transactions

EDGAR

PALOMINO LABORATORIES INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-20.

Open-market purchases (code P)
2 transactions, 25,000 shares
Sum of shares × price per share: 100,000
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–3 of 3

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-07-31 Filed 2026-08-04Ogawa Richard Director · Officer: Secretary
J

Other acquisition or disposition (describe transaction)

Common Stock
Acquired (A)120,0005.14
616,800

Derived: shares × price per share. Exact value 616800.00.

1,882,500Direct (D) No
F1
  • F1 Pursuant to the terms of a certain Share Exchange Agreement and Plan of Reorganization, dated as of July 31, 2026, by and among Palomino Laboratories Inc. (the Purchaser), Vega Links, Inc. (VLI) and the stockholders as listed on Schedule A attached thereto (the Stockholders), the Stockholders, who directly owned one hundred percent (100%) of the shares of VLI (the Shares), sold all the Shares to the Purchaser in exchange for 4,472,000 shares of the common stock, par value $0.0001 per share of the Purchaser (Purchaser Stock). As part of this transaction, Richard Ogawa, as a shareholder of VLI, received 120,000 shares of Purchaser Stock in exchange for his 300,000 shares of VLI.
Open filing 0001493152-26-035982 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-04-20Ogawa Richard Director · Officer: Secretary
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)12,5004
50,000

Derived: shares × price per share. Exact value 50000.

1,762,500Direct (D) No— Open filing 0001493152-26-018119 Read from the filing’s XML Dispute this row
2026-04-20 Filed 2026-04-20Denbaars Steven Director
P

Open market or private purchase of non-derivative or derivative security

Common Stock
Acquired (A)12,5004
50,000

Derived: shares × price per share. Exact value 50000.

1,762,500Direct (D) No— Open filing 0001493152-26-018116 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

No Form 13F position in this issuer is placed in the store. A holder not yet linked or not yet filed is absent, not zero.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Richard Ogawa Common Stock, par value $0.0001 per share6.91,882,500.0007/31/2026 Filed 2026-08-21SCHEDULE 13D/AAmendment 1Open filing 0001493152-26-039653 Dispute this row
Shealy Jeffrey B. Common Stock, par value $0.0001 per share23.84,666,666.0009/29/2025 Filed 2025-10-27SCHEDULE 13DOpen filing 0001493152-25-019712 Dispute this row
Richard Ogawa Common Stock, par value $0.0001 per share9.41,750,000.0009/29/2025 Filed 2025-10-08SCHEDULE 13DOpen filing 0001493152-25-017501 Dispute this row
Steven DenBaars Common Stock, par value $0.0001 per share9.41,750,000.0009/29/2025 Filed 2025-10-07SCHEDULE 13DOpen filing 0001493152-25-017262 Dispute this row
Matthew Eitner Common Stock, $0.0001 par value per share234,000,000.0009/29/2025 Filed 2025-10-06SCHEDULE 13D/AAmendment 1Open filing 0001213900-25-096685 Dispute this row
Lucius Partners LLC Common Stock, $0.0001 par value per share234,000,000.0009/29/2025 Filed 2025-10-06SCHEDULE 13D/AAmendment 1Open filing 0001213900-25-096685 Dispute this row
Matthew Eitner Common Stock, $0.0001 par value per share1005,000,000.0010/09/2023 Filed 2025-10-06SCHEDULE 13DOpen filing 0001213900-25-096683 Dispute this row
Lucius Partners LLC Common Stock, $0.0001 par value per share1005,000,000.0010/09/2023 Filed 2025-10-06SCHEDULE 13DOpen filing 0001213900-25-096683 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,615,281 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
201532,368
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,123

Filings made before the SEC required XML are listed, not extracted.

Back to PALOMINO LABORATORIES INC.